To follow/participate go to #tct2011 from your account at www.twitter.com

BOSTON--(BUSINESS WIRE)-- Experts from Harvard Clinical Research Institute (HCRI), a leading international provider of clinical trial services, will be in attendance at TCT (Transcatheter Cardiovascular Therapeutics) 2011 (Booth # 1434) and will tweet commentary and insights from the event in San Francisco, Nov. 8-10.

“We look forward to participating at TCT 2011 and to sharing the insights of HCRI faculty with the international cardiology community,” said Mordecai Kramer, Executive Director, Business Development, HCRI.

About Harvard Clinical Research Institute (HCRI)

HCRI (www.hcri.harvard.edu) is a not-for-profit organization that advances the research of pharmaceuticals, biologics, and medical devices by developing collaborations between industry and academia.

CONTACT:

Ronald Trahan Associates Inc.
Ronald Trahan, +1 508-816-6730
President
rctrahan@ronaldtrahan.com
or
HCRI
Devan Rousseau, +1-617-307-5527
Business Development Associate
devan.rousseau@hcri.harvard.edu

KEYWORDS:   United States  North America  Massachusetts

INDUSTRY KEYWORDS:   Health  Biotechnology  Clinical Trials  Medical Devices  Research  Science

MEDIA:

Logo